Navina · Series C

Amount

$55M

Round

Series C

Valuation

—

Announced

—

Investors

Lead investor

Growth Equity at Goldman Sachs Alternatives

Participating investors

Vertex Ventures Israel Grove Ventures ALIVE Israel HealthTech Fund